摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[3-(3,4-dihydroxy-phenyl)-acryloylamino]-3-(4-hydroxy-phenyl)propionic acid methyl ester | 582311-48-6

中文名称
——
中文别名
——
英文名称
2-[3-(3,4-dihydroxy-phenyl)-acryloylamino]-3-(4-hydroxy-phenyl)propionic acid methyl ester
英文别名
N-[3′,4′-dihydroxy-(E)-cinnamoyl]-L-tyrosine methyl ester;N-(3,4-dihydroxy-E-cinnamoyl)-L-tyrosine methyl ester;N-caffeoyl-L-tyrosine methyl ester;N-caffeoyl-tyrosine methyl ester;caffeoyl tyrosine methyl ester;(R)-2-[trans-3-(3,4-dihydroxy-phenyl)-acryloylamino]-3-(4-hydroxy-phenyl)-propionic acid methyl ester;methyl (2S)-2-[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino]-3-(4-hydroxyphenyl)propanoate
2-[3-(3,4-dihydroxy-phenyl)-acryloylamino]-3-(4-hydroxy-phenyl)propionic acid methyl ester化学式
CAS
582311-48-6
化学式
C19H19NO6
mdl
——
分子量
357.363
InChiKey
WCKQISDLXKTVDV-BOSPYUDASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    683.2±55.0 °C(Predicted)
  • 密度:
    1.362±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    26
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.16
  • 拓扑面积:
    116
  • 氢给体数:
    4
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-[3-(3,4-dihydroxy-phenyl)-acryloylamino]-3-(4-hydroxy-phenyl)propionic acid methyl ester 、 lithium hydroxide 作用下, 以 四氢呋喃 为溶剂, 反应 1.0h, 以72%的产率得到N-[(2E)-3-(3,4-二羟基苯基)-2-丙烯酰基]酪氨酸
    参考文献:
    名称:
    使用生物等排替代合成和评价结核分枝杆菌 UGM 抑制剂
    摘要:
    由于耐药结核病的出现,目前的治疗方法不足,因此缺乏结核病 (TB) 药物开发活动。酶 UDP-吡喃半乳糖变位酶 (UGM) 参与半乳聚糖的生物合成,这对细胞壁完整性和细菌活力至关重要。因此,它的抑制被认为是抗结核药物发现的有利可图的策略。在这项研究中,我们报告了从迷迭香酸衍生的酰胺的合成,它们使用三种不同的生化测定法对纯化的 UGM 的抑制作用:FP、HPLC 和 SPR。与相应的迷迭香酸酯相比,迷迭香酰胺通常对UGM显示出显着更高的亲和力。特别是,化合物5 h显示出有趣的结合亲和力值 ( Kd  = 58 ± 7, 63 ± 9 µM 分别朝向Kp UGM 和Mt UGM)。此外,建立了一种新的 UGM SPR 测定,并证实5小时与 UGM 结合,解离常数为 104.8 ± 6.5 μM。总的来说,这项研究验证了酰胺生物等排策略,该策略已成功实施以从迷迭香酸开发 UGM 抑制剂,为进一步设计新型
    DOI:
    10.1016/j.bmc.2022.116896
  • 作为产物:
    参考文献:
    名称:
    氯丁酰胺及其相关化合物抑制淀粉样蛋白β聚集的构效关系。
    摘要:
    阿尔茨海默氏病(AD)是一种神经退行性疾病,其特征是淀粉样β蛋白(Aβ)聚集。Aβ通过β折叠形成聚集,并诱导针对神经元细胞的细胞毒性。因此,天然存在的化合物抑制Aβ聚集是治疗AD的有前途的策略。我们已经报道了具有两个或多个邻苯二酚部分的咖啡酰奎尼酸和苯乙酮类糖苷强烈抑制了Aβ聚集。从可可豆(Theobroma cacao L.)分离的含有两个邻苯二酚部分的环丙酰胺(1)被认为对Aβ聚集具有预防作用。为了研究氯丁酰胺(1)抑制Aβ聚集的构效关系,我们通过1-DOPA,d-DOPA,l-酪氨酸,或l-苯丙氨酸和咖啡酸,对香豆酸或肉桂酸,化合物12和13衍生自1。在测试的化合物1-13中,含有一个或两个邻苯二酚部分的化合物表现出强的抗聚集活性,而非儿茶酚类相关化合物几乎没有活性。这表明至少一个儿茶酚部分对于抑制Aβ42聚集是必不可少的,并且该活性根据儿茶酚部分的数目而增加。因此,clovamid
    DOI:
    10.1016/j.bmc.2018.04.044
点击查看最新优质反应信息

文献信息

  • Synthesis and biological evaluation of clovamide analogues with catechol functionality as potent Parkinson’s disease agents in vitro and in vivo
    作者:Jia-Hao Feng、Xiao-Long Hu、Xian-Yu Lv、Bao-Lin Wang、Jun Lin、Xiao-Qi Zhang、Wen-Cai Ye、Fei Xiong、Hao Wang
    DOI:10.1016/j.bmcl.2018.11.030
    日期:2019.1
    • In this study, seven clovamide analogues (1–7) were designed and synthesized, and the neuroprotection of 1–7 as well as 8–15 (prepared in our previous work) against H2O2-induced oxidative stress was evaluated in SH-SY5Y cells. Results showed that 1–7 with catechol groups exhibited better neuroprotective effects than 8–15, and their EC50 values ranged from 4.26 to 23.83 μM, especially 1, indicating
    • 在这项研究中,设计并合成了7种氯仿酰胺类似物(1 – 7),并在SH中评估了1 – 7以及8 – 15(在我们先前的工作中制备)对H 2 O 2诱导的氧化应激的神经保护作用。-SY5Y细胞。结果表明,1 - 7与儿茶酚基团表现出比更好的神经保护作用8 - 15,以及它们的EC 50值从4.26到不等23.83μM,特别是1,表明邻苯二酚的部分支配了这些化合物的活性。此外,口服1(10或20 mg / kg)被证明具有通过减轻体内和体外细胞凋亡和氧化应激以及上调血红素加氧酶-1(HO-1)的表达而具有抗PD的作用。 )通过PI3K / AKT / mTOR途径进行。最后,在大鼠中确定1的药代动力学(PK)评估。这些发现表明1可能是PD治疗的有效候选者。
  • Synthesis and evaluation of caffeic acid amides as antioxidants
    作者:Padinchare Rajan、Irina Vedernikova、Paul Cos、Dirk Vanden Berghe、Koen Augustyns、Achiel Haemers
    DOI:10.1016/s0960-894x(00)00630-2
    日期:2001.1
    A series of amides of caffeic acid has been synthesised and their antioxidant properties evaluated as lipid peroxidation inhibitors. Anilides of caffeic acid were found to be very efficient antioxidants with IC50's of 0.3 microM.
    已经合成了一系列咖啡酸酰胺,并评估了它们的抗氧化性能作为脂质过氧化抑制剂。发现咖啡酸的苯甲酸酯是非常有效的抗氧化剂,IC50为0.3 microM。
  • Hydroxycinnamoyl Amino Acids Conjugates: A Chiral Pool to Distinguish Commercially Exploited Coffea spp.
    作者:Federico Berti、Luciano Navarini、Silvia Colomban、Cristina Forzato
    DOI:10.3390/molecules25071704
    日期:——

    The synthesis of five hydroxycinnamoyl amides (HCAs) was accomplished and their identification and quantification in the green coffee bean samples of Coffea arabica, Coffea canephora, and Coffea liberica was performed. The HCAs p-coumaroyl-N-tyrosine 1b, caffeoyl-N-phenylalanine 2b, caffeoyl-N-tyrosine 3b, and p-coumaroyl-N-tryptophan 4b were characteristic of the C. canephora species while caffeoyl-N-tryptophan 5b was present in both C. canephora and C. arabica, but with higher content in C. canephora. The HCAs presence was also analyzed in C. liberica for the first time and none of the targeted compounds was found, indicating that this species is very similar to C. arabica species. Between C. canephora samples from various origins, significant differences were observed regarding the presence of all the HCAs, with C. canephora from Tanzania containing all five derivatives.

    合成了五种羟基肉桂酰胺(HCAs),并对咖啡属(Coffea arabica,Coffea canephora和Coffea liberica)的绿咖啡豆样品进行了它们的鉴定和定量。HCAs对C. canephora物种具有特征性,其中p-香豆酰-N-酪氨酸1b,咖啡酰-N-苯丙氨酸2b,咖啡酰-N-酪氨酸3b和p-香豆酰-N-色氨酸4b。咖啡酰-N-色氨酸5b存在于C. canephora和C. arabica中,但在C. canephora中含量更高。首次分析了C. liberica中的HCAs存在,并且没有发现任何目标化合物,表明该物种与C. arabica物种非常相似。在来自不同地区的C. canephora样品中,观察到所有HCAs的存在方面存在显着差异,坦桑尼亚的C. canephora含有所有五种衍生物。
  • Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition
    申请人:——
    公开号:US20040082664A1
    公开(公告)日:2004-04-29
    The present invention relates to derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition, more particularly the compounds of the present invention specifically inhibit the activation of T lymphocyte by src homology region 2(SH2) domain of T lymphocyte (lck), so that they can be used for the treatment, prevention and/or diagnosis of graft rejection, autoimmune diseases, inflammatory diseases, etc.
    本发明涉及羟基苯基衍生物、其制备方法及其药物组合物,更具体地,本发明的化合物特异性地抑制T淋巴细胞的src同源区域2(SH2)结构域(lck),从而可用于移植排斥、自身免疫性疾病、炎症性疾病等的治疗、预防和/或诊断。
  • Synthesis of Lipophilic Clovamide Derivatives and Their Antioxidative Potential against Lipid Peroxidation
    作者:Jakob P. Ley、Heinz-Jürgen Bertram
    DOI:10.1021/jf034286d
    日期:2003.7.1
    Some N-(hydroxycinnamoyl)-L-tyrosine and L-DOPA alkyl esters were synthesized and evaluated as a variation of the clovamide (N-caffeoyl-L-3,4-dihydroxyphenylalanine) structure, a known antioxidant found in red clover. The amides were prepared in good yields starting from methyl and dodecylesters Of L-tyrosine and L-DOPA by reacting with the N-hydroxysuccinimidyl esters of ferulic, sinapic, and acetyl-protected caffeic acid, respectively. In the DPPH. (2,2-diphenyl-1-picrylhydrazyl) and superoxide radical quencher assays they showed radical scavenging activity equal to or higher than those of the standard antioxidants ascorbic acid and tocopherol. The antioxidative potentials of the clovamide derivatives against bulk lipid oxidation, as determined by the accelerated autoxidation of oils, were equal to or higher than those of the standard antioxidants; some of the compounds were able to protect an emulsion of linoleic acid/beta-carotene against oxidation. N-Caffeoyl L-tyrosine methyl ester and the N-cinnamoyl L-DOPA alkyl esters especially were potent antioxidants in bulk lipids and moderate protectants in emulsions.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物